IMS Health Holdings Inc. (IMS) Upgraded by Zacks Investment Research to “Buy”
Zacks Investment Research upgraded shares of IMS Health Holdings Inc. (NYSE:IMS) from a hold rating to a buy rating in a research report report published on Wednesday. Zacks Investment Research currently has $34.00 target price on the stock.
According to Zacks, “IMS Health Holdings, Inc. engages in providing information, services, and technology to the healthcare industry worldwide. The company develops healthcare measurement solutions, such as IMS LifeLink program, IMS NPA Market Dynamics, IMS Xponent Prescribing Dynamics, IMS PlanTrak Market Dynamics, and Specialty Market Dynamics. It serves pharmaceutical, payers, government, providers, pharmacies, consumer health, pharmaceutical distribution, and financial community sectors. The company also provides consumer health insights, forecasting solutions, payer insights, pharmaceutical measurement solutions, and publications. IMS Health Holdings, Inc. is based in Danbury, Connecticut. “
Separately, TheStreet lowered shares of IMS Health Holdings from a buy rating to a hold rating in a research report on Monday, August 29th. Three research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The stock presently has an average rating of Buy and an average target price of $31.00.
Shares of IMS Health Holdings (NYSE:IMS) opened at 30.53 on Wednesday. The firm has a market cap of $10.05 billion, a P/E ratio of 74.10 and a beta of 0.85. The company has a 50-day moving average of $29.71 and a 200 day moving average of $27.25. IMS Health Holdings has a 12-month low of $22.36 and a 12-month high of $31.59.
IMS Health Holdings (NYSE:IMS) last issued its quarterly earnings data on Wednesday, July 27th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.03. The firm had revenue of $802 million for the quarter, compared to analyst estimates of $796.93 million. IMS Health Holdings had a net margin of 4.45% and a return on equity of 30.61%. The company’s revenue for the quarter was up 112.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.37 earnings per share. Equities research analysts anticipate that IMS Health Holdings will post $1.64 earnings per share for the current fiscal year.
Large investors have recently modified their holdings of the stock. Acrospire Investment Management LLC increased its stake in shares of IMS Health Holdings by 31.3% in the second quarter. Acrospire Investment Management LLC now owns 4,200 shares of the company’s stock valued at $107,000 after buying an additional 1,000 shares in the last quarter. Nordea Investment Management AB increased its stake in shares of IMS Health Holdings by 9.3% in the second quarter. Nordea Investment Management AB now owns 4,811 shares of the company’s stock valued at $122,000 after buying an additional 411 shares in the last quarter. LS Investment Advisors LLC increased its stake in shares of IMS Health Holdings by 14.0% in the second quarter. LS Investment Advisors LLC now owns 4,982 shares of the company’s stock valued at $126,000 after buying an additional 611 shares in the last quarter. BNP Paribas Arbitrage SA increased its stake in shares of IMS Health Holdings by 83.8% in the second quarter. BNP Paribas Arbitrage SA now owns 4,993 shares of the company’s stock valued at $127,000 after buying an additional 2,276 shares in the last quarter. Finally, Seven Eight Capital LLC purchased a new stake in shares of IMS Health Holdings during the first quarter valued at approximately $191,000. Institutional investors own 90.25% of the company’s stock.
IMS Health Holdings Company Profile
IMS Health Holdings, Inc (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company’s data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.
Receive News & Stock Ratings for IMS Health Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMS Health Holdings Inc. and related stocks with our FREE daily email newsletter.